[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Infection Prevention (2/4)

Last updated on: 8/1/2024

COVID-19 and bispecific antibody therapy

The risk of severe COVID-19 complications and death for patients receiving bispecific antibody therapy has significantly decreased due to advancements in:

  • Antiviral prophylaxis: Effective antiviral medications can now be used preventatively to significantly reduce the chances of developing severe COVID-19 infection.
  • Immunoglobulin replacement therapy (IVIG): For patients with low immunoglobulin levels, intravenous immunoglobulin infusions can further strengthen their immune system and help them fight infections, including COVID-19.